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Case Report
Pediatric/Craniofacial
A Case of Pediatric Melanoma: Treatment
Considerations in Advanced Disease
Frank P. Albino, MD
Benjamin C. Wood, MD
Albert Oh, MD
Gary F. Rogers, MD, JD, MBA,
MPH
Tina Sauerhammer, MD

Summary: We document a 3-year-old healthy African American girl who
developed malignant melanoma on her lower extremity. The clinical
appearance offered little indication of the lesion’s severity (T4), and only
the history of de novo presentation and disproportionate growth raised
clinical suspicion. This case report highlights the subtle clinical findings
of this condition and presents controversies related to surgical management of pediatric melanoma. (Plast Reconstr Surg Glob Open 2015;3:e402;
doi: 10.1097/GOX.0000000000000370; Published online 18 May 2015.)

E

ach year, more than 76,000 new cases of melanoma are diagnosed in the United States.1 Pediatric melanomas account for 0.7% of all cases
and 0.1% of subsequent mortalities. The incidence of
pediatric melanoma rises 2.6% annually, which may
be partially explained by changes in sun-related behavior, yet the use of tanning beds and increases in
ultraviolet exposure do not account for rises in prepubertal populations.1–3 As the number of children diagnosed with melanoma continues to rise, accurate and
timely diagnosis and treatment becomes even more
paramount. Clinical suspicion remains the cornerstone of diagnosis and depends on an appreciation
of the unique clinical features of pediatric melanoma.
Risk factors for melanoma common to both pediatric and adult populations include Fitzpatrick 1 skin
phenotype, positive family history, previous malignancies, concomitant medical conditions such as xeroderma pigmentosum, and chronic immunosuppression.3,4
In contrast to established risk factors for adults, sun exposure does not correlate with prepubertal, pediatric
melanoma. Rates of disease are highest in areas of low
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ultraviolet-B exposure based on geographic location
in that patient population.1–3 The incidence of melanoma in adolescents, on the other hand, more closely
mirrors the adult melanoma population correlation
with increased ultraviolet-B exposure.
Traditional detection criteria used in adults often
fail to identify malignant lesions in children. Suspicious clinical findings in children include amelanosis,
bleeding, raised lesions, color uniformity, and de novo
lesion development.3,5 Furthermore, classic prognostic features, including tumor depth of invasion and
lymph node involvement, less clearly impact survival
in children.6,7 We report on a case of melanoma in
a 3-year-old patient to address the clinical features of
this disease in the pediatric population and review
some of the factors used to guide treatment options.

CLINICAL REPORT

A 3-year-old African American girl was referred to
our office at the request of her dermatologist for a de
novo, suspicious lower extremity lesion. On physical
examination, she demonstrated a 0.6 × 0.5 cm, raised,
darkly pigmented, well circumscribed anterior right
knee lesion (Fig. 1). There was no ulceration, bleeding, or surrounding skin changes. The patient was
healthy. She had no medical conditions and took
no medications, and there was no personal or family history of skin cancer. An excisional biopsy was
performed with wide local excision. Histologic evaluation demonstrated malignant melanoma, nevoid
type, with a 4.95 mm tumor depth (T4) characterized
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Fig. 2. Digital photograph of the lesion visualized with hematoxylin and eosin stain with high mitotic activity, poor cellular
maturation, and atypical melanocytes (×20 magnification).

Fig. 1. Three-year-old girl with right anterior knee lesion.

by high mitotic activity, poor maturation, and junctional/dermal proliferation of atypical melanocytes
(Fig. 2). Immunohistochemical staining established
loss of p16 expression.
The patient returned to the operating room 3
weeks later for lymphoscintigraphy using 0.4 mCi of
technetium 99m injected in 4 doses along the previous
surgical scar. A single sentinel lymph node was identified and removed immediately preceding a longitudinal reexcision of the biopsy scar with a 2-cm margin
and primary closure. Unfortunately, the sentinel node
was positive for a focus of metastatic disease, and ultimately, the patient underwent radical groin dissection,
which was negative for any residual nodal involvement.

DISCUSSION

In contrast to the established diagnostic, therapeutic, and prognostic criteria for adult melanoma,
the clinical features of pediatric melanoma are poorly
characterized. Traditional “ABCD” detection criteria must be expanded for pediatric screening to include amelanosis, color uniformity, and newly arising
lesions.5 Diagnosing pediatric melanoma is further
complicated by histologic similarities with some forms
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of benign melanocyte proliferation. Large congenital melanocytic nevi (CMN) remain a main risk factor for pediatric melanoma; patients with CMN have
a 52% higher risk of melanoma compared with the
general population. This risk is greatest for patients
with large CMN of the trunk, lesions greater than
20 cm, and multiple satellite nevi.8,9 Moreover, 16% of
melanomas are initially misdiagnosed as Spitz nevi.1,4
Lymph node biopsies have been advocated to aid in
obtaining the correct diagnosis.7 Gill et al10 found that
B-RAF, N-RAS, and H-RAS mutations are unique to
spitzoid melanomas compared with the Spitz nevi.1
In the adult population, sentinel lymph node biopsy (SLNP) is an important staging procedure with
prognostic implications.6,7,11,12 The prognostic role of
SLNB for pediatric melanoma has not yet been determined. Roaten et al6 have demonstrated, however,
that SLNB correlates with tumor depth and is safe
without mortalities or recurrences over 35 months of
follow-up. By contrast, the adult cohort of this study
had fewer cases of sentinel lymph node involvement
(18%) but overall fared worse with a 25% recurrence
rate and 9% mortality rate within 19 months from
their SLNB.6 Whether there is a greater propensity
for nodal metastasis, a delay in clinical diagnosis,
or another explanation, remains to be determined;
however, pediatric melanoma frequently involves local lymph node basins. The prognostic implications
for a positive SLNB on recurrence and survival are
either not supported or not yet established.5–7,13 Once
nodal involvement has been established, the need for
further therapeutic intervention remains unclear. It
is important to carefully discuss the known morbidity
of completion lymph node dissection (CLND) in the
context of its undetermined benefit. Fourteen percent of patients with a positive sentinel lymph node
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will have residual tumor draining to their lymph node
basin, which may be detected by CLND.7 Complication rates following CLND approach 60%, including
lymphedema (19–28%) and infection (17–28%).7,13
As with SLNB, the benefit of CLND for pediatric
melanoma is largely unknown. To extrapolate from
adult data, however, 5-year survival rates are higher
following immediate CLND (72.3%) in patients with
node-positive disease compared with delayed lymphadenectomy when clinically apparent regional node
metastasis develop (52.4%).11
Our patient with stage III melanoma and nodepositive T4 tumor bears a 5-year survival rate estimated
at 77%. Nevertheless, her age and the absence of
tumor ulceration may prove more favorable characteristics that improve her prognosis.4 The family
elected to pursue a CLND despite a candid discussion about the minor risks involved with the procedure and the inconclusive benefits of the procedure.
Her procedure went well and she is undergoing
medical adjuvant treatment of her cancer. As additional cases of pediatric melanoma arise, long-term
outcomes need to be evaluated to determine the
appropriate surgical management of these tumors to
most accurately counsel patients and their families.
Tina Sauerhammer, MD
Division of Plastic Surgery
Children’s National Medical Center
111 Michigan Avenue NW
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PATIENT CONSENT

Parents or guardians provided written consent for the
use of the patient’s image.
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